Overview

Adelee Traylor is a business transactions attorney who guides clients in health care, life sciences, and other industries—from startups to Fortune 500 companies—through all aspects of intellectual property (IP) and technology matters. 

Her transactional work includes structuring and negotiating international and domestic technology and IP transactions, including technology transfer and licensing arrangements, outsourcing transactions, research and development activities, and joint ventures. Adelee has extensive experience in complex software agreements, such as licensing, development, hosting, SaaS, PaaS, and other marketing and services agreements. Clients also seek her advice in connection with the protection and enforcement of IP, including the clearance, use, registration, maintenance, and opposition of IP rights and assets.

Adelee counsels clients on all aspects of IP auditing and portfolio management, IP strategy development, competitive analysis, and IP monetization. In addition, she provides advice on the IP and technology aspects of corporate transactions, including mergers and acquisitions, and handles IP due diligence reviews.

Read more

Adelee has worked with clients of all sizes, including emerging companies, universities, research institutions, and multinational companies, in many different technology areas, including biopharmaceuticals, consumer products, data science, e-commerce, health care, manufacturing, medical devices, pharmaceuticals, and software.

Aside from her IP work, Adelee is experienced in the drafting and negotiation of agreements relating to the conduct of medical research, such as clinical trials, investigator-initiated studies, and the sharing of data and materials inside and outside the United States, and interfacing with research organizations, government entities, clinical research organizations, and third-party suppliers on behalf of pharmaceutical and medical device companies.

Additionally, Adelee gives her time to various pro bono endeavors, including having served as a pro bono attorney for the Legal Aid Society of Middle Tennessee and the Cumberlands, Room In the Inn, Arts & Business Council of Greater Nashville, and the Nashville Entrepreneur PreFlight Program.

In 2023, Adelee mentored a cohort for the FemHealth Accelerator program, which supports women entrepreneurs in building technology-enabled, consumer-centric products and solutions that drastically improve women's health and fitness.

Before joining Epstein Becker Green, Adelee was a partner at a national technology law firm. Prior to that, she was a partner at a national law firm, where she counseled clients in connection with IP protection and technology commercialization activities and prosecuted patents in diverse technology areas. Earlier in her career, Adelee spent time in-house at a university technology transfer office, a hospital system, and a large pharmaceutical company to gain an understanding of the business of IP and technology law from the client perspective.

Read less

Focus Areas

Recognition

  • The Best Lawyers in America®
    • Ones to Watch: Patent Law (2022 to 2024)
    • Ones to Watch: Trademark Law (2022 to 2024)
  • Middle Tennessee Chapter of the Cystic Fibrosis Foundation, Nashville’s Top 30 Under 30 (2019)
  • American Bar Association, Top 40 Young Lawyer Award Nominee (2019)

Credentials

Education

  • Oklahoma University College of Law (J.D./M.P.H. in Administration and Policy, 2014)
  • University of Central Oklahoma (B.S., magna cum laude, 2010)

Bar Admissions

Professional & Community Involvement

  • Dallas Bar Association
    • Intellectual Property Section
    • Women’s Section
  • Moves & Grooves, Inc., Board Member (2018 to 2020)
  • Texas Bar Association
    • Intellectual Property Section
    • Women’s Section
  • VEST Her Member, FemHealth Accelerator Mentor (2023)

Media

Events

Upcoming Events

Past Events

  • Tennessee Bar Association, Intellectual Property Law Forum: Well, Doc, We Made It Past 2020
  • MENT Women’s Conference: Brand Development and IP Protection
  • Graphene Innovation & Research Conference: Graphene Intellectual Property Landscape
    November 2019
  • Global Graphene Expo and Conference: Intellectual Property Protection in Graphene
    October 2018
  • In-House Counsel CLE: Third-Party Use of Intellectual Property
    March 2017

Insights

Certifications

  • Certified Biomedical Researcher, Collaborative IRB Training Initiative (CITI)
  • U.S. Patent and Trademark Office, Registered
Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.